According to IMARC Group’s latest report, titled “Canine Atopic Dermatitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.’ The study provides a detailed analysis of the industry, including the global canine atopic dermatitis market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How Big is the Canine Atopic Dermatitis Market?
The global canine atopic dermatitis market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2028, exhibiting a growth rate (CAGR) of 15.5% during 2023-2028.
What is Canine Atopic Dermatitis?
Canine atopic dermatitis (CAD) is a common and chronic skin disorder in dogs, characterized by intense itching and inflammation. It's akin to eczema in humans. CAD usually arises from an allergic reaction to environmental allergens like pollen, mold spores, dust mites, or certain foods. These allergens trigger an inappropriate immune response in the dog, leading to skin irritation. Symptoms include frequent scratching, licking, or chewing on skin, redness, rashes, and hair loss, typically around the ears, paws, underarms, and belly. Secondary infections due to constant scratching can further complicate the condition. Diagnosis is often through the elimination of other causes and allergy testing. Treatment includes managing the symptoms through medications, dietary changes, and minimizing exposure to known allergens.
Request for a PDF Sample of this Report: https://www.imarcgroup.com/canine-atopic-dermatitis-market/requestsample
What are the growth prospects and trends in the canine atopic dermatitis industry?
The market is primarily driven by the rising incidences of atopic dermatitis in dogs triggered due to air pollution and allergens. In addition, the growing awareness among pet owners about early signs and symptoms of allergic reaction and the increasing adoption of pet insurance is positively influencing the market growth. Furthermore, the rapid development of advanced therapeutic methods to control symptoms in animals represents another key factor driving the global market. Moreover, rising environmental factors responsible for allergies and increasing research and development (R&D) investment by the key industry players in the field of veterinary sciences are anticipated to propel the market growth in the upcoming years.
Who are the key players operating in the industry?
The report covers the major market players including:
- AB Science
- Bimeda Inc.
- Bioceltix SA
- Boehringer Ingelheim International GmbH
- Ceva Santé Animale
- Dechra Pharmaceuticals PLC
- Elanco Animal Health Incorporated
- Phibro Animal Health Corporation
- Toray Industries Inc.
- Vetoquinol S.A.
- Virbac and Zoetis Inc.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Drug Class Type:
- Glucocorticoids
- Immunosuppressants
- Monoclonal Antibody
- Others
Breakup by Route of Administration:
- Topical
- Oral
- Injectable
Breakup by Distribution Channel:
- Veterinary Hospitals
- Pet Clinics
- Pharmacies and Drugstores
- Others
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Ask Analyst for Customized Report: https://www.imarcgroup.com/request?type=report&id=4700&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com
